Third‐line systemic treatment for non‐small cell lung cancer

This is a protocol for a Cochrane Review (Intervention). The objectives are as follows: In patients with advanced (Stage IIIB and IV) NSCLC with EGFR wild‐type, unknown status of EGFR, or with EGFR activating mutations (Mountain 1997), to assess in terms of OS and PFS the clinical efficacy of third‐...

Descripción completa

Guardado en:
Detalles Bibliográficos
Publicado en:Cochrane Database Syst Rev
Autores principales: Kim, Stefano C, Paget‐Bailly, Sophie, Trinquart, Ludovic, Calais, François, Bonnetain, Franck, Westeel, Virginie
Formato: Artigo
Lenguaje:Inglês
Publicado: John Wiley & Sons, Ltd 2014
Materias:
Medicine General & Introductory Medical Sciences
Acceso en línea:https://ncbi.nlm.nih.gov/pmc/articles/PMC6491211/
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/14651858.CD011291
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares